National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019

Laurie D. Elam-Evans, PhD; David Yankey, PhD; James A. Singleton, PhD; Natalie Sterrett, MPH; Lauri E. Markowitz, MD; Charnetta L. Williams, MD; Benjamin Fredua, MS; Lucy McNamara, PhD; Shannon Stokley, DrPH


Morbidity and Mortality Weekly Report. 2020;69(33):1109-1116. 

In This Article

Vaccination Coverage By Selected Characteristics

In 2019, compared with adolescents living in MSA principal cities, coverage with ≥1 dose of HPV vaccine among those living in non-MSA areas was 9.6 percentage points lower, the percentage who were HPV UTD was 9.8 percentage points lower, and coverage with ≥1 dose of MenACWY was 5.1 percentage points lower. These disparities were only observed among adolescents living at or above the poverty level (Table 2). Coverage with all vaccine doses recommended for adolescents varied by jurisdiction, with differences ranging from 15 percentage points for ≥1 Tdap dose to 48.4 percentage points for being HPV UTD (Supplementary Table, Differences were observed in vaccination coverage by race and ethnicity§§§ and by health insurance status.¶¶¶